BlackRock Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $193K | Sell |
18,554
-558
| -3% | -$5.8K | ﹤0.01% | 2663 |
|
|
2016
Q3 | $173K | Buy |
19,112
+2,581
| +16% | +$23.4K | ﹤0.01% | 2694 |
|
|
2016
Q2 | $124K | Buy |
16,531
+676
| +4% | +$5.07K | ﹤0.01% | 2802 |
|
|
2016
Q1 | $143K | Buy |
15,855
+6,781
| +75% | +$61.2K | ﹤0.01% | 2682 |
|
|
2015
Q4 | $117K | Sell |
9,074
-2,619
| -22% | -$33.8K | ﹤0.01% | 2805 |
|
|
2015
Q3 | $113K | Sell |
11,693
-9,487
| -45% | -$91.7K | ﹤0.01% | 2999 |
|
|
2015
Q2 | $218K | Buy |
21,180
+17,494
| +475% | +$180K | ﹤0.01% | 2706 |
|
|
2015
Q1 | $41K | Buy |
3,686
+460
| +14% | +$5.12K | ﹤0.01% | 3265 |
|
|
2014
Q4 | $38K | Hold |
3,226
| – | – | ﹤0.01% | 3293 |
|
|
2014
Q3 | $71K | Sell |
3,226
-50,846
| -94% | -$1.12M | ﹤0.01% | 3133 |
|
|
2014
Q2 | $1.5M | Buy |
+54,072
| New | +$1.5M | ﹤0.01% | 1239 |
|